NEPHSTROM

NEPHSTROM receives funding from the @EU_H2020 Research & Innovation Programme. Tweets reflect only the views of the project owner.

[NEPHSTROM @nephstrom]

NEPHSTROM will deliver and validate a transformative mesenchymal stromal cell (MSC) treatment, ORBCEL-M. MSCs have demonstrated the potential to target the five major aspects of diabetic kidney disease – hypertension, inflammation, fibrosis, oxidative stress, and proteinuria.

[Frontiers - Immunology @FrontImmunol]

New Research: Expanded Hemodialysis Therapy Ameliorates Uremia-Induced Systemic Microinflammation and Endothelial Dysfunction by Modulating VEGF, TNF-α and AP-1 Signaling: Abstract Systemic chronic microinflammation and altered cytokine… https://t.co/RDU7llCIVT #immunology

[NEPHSTROM @nephstrom]

On October 31, 2021, NEPHSTROM came to the end of its funded period. NEPSTROM conducted a multi-centre, placebo-controlled clinical trial of a novel MSC therapy for stabilization of progressive diabetic kidney disease and will continue the clinical trial.https://t.co/V9iSOeLatV

[JASN_News @JASN_News]

This study found that SARS-CoV-2 infection delays the IgG response, but not IgA and IgM responses, in kidney transplant recipients, which may contribute to their risk of poor outcome in COVID-19 https://t.co/aIX3GNoeNu

@jonmaltzman

[AutoCRAT @AutoCRAT2020]

@UniGenova: Role of extracellular vesicles from adipose tissue- and bone marrow-mesenchymal stromal cells in endothelial proliferation and chondrogenesis @cansulina Gorgun, @elybasetta Palamà, Daniele Reverberi, Maria Cristina Gagliani, Katia Cortese, Roberta Tasso Chiara Gentili

[NEPHSTROM @nephstrom]

@PennMedicine study in @NatureGenet provides one of the clearest pictures to date of the genetic underpinnings of chronic kidney disease unlocking the genetic 'treasure map' for #CKD. https://t.co/NAyXZVyCkp

[AutoCRAT @AutoCRAT2020]

Danielle Nicholson @dmnicholson of @PintailLimited spoke with @LUMC_Leiden Profs. Ingrid Meulenbelt, @MeulenbeltI and F. M. Ramos @ramos_yfm via Zoom to kick off our series of interviews with women researchers in AutoCRAT. https://t.co/Z19zRlvy1K

[Ollscoil na Gaillimhe | University of Galway @uniofgalway]

Keep yourself, your colleagues, your family and your community safe through regular rapid #COVID19 and saliva PCR testing during #projectunicov. The need for #COVID19 detection and control will remain with us for some time. Please help! 👉 https://t.co/DtefYn1XYe @BredaSmyth4

[NEPHSTROM @nephstrom]

Largest-ever type 1 #diabetes genetic study identifies potential treatment targets https://t.co/uVeooVTMNY via @medical_xpress

[NEPHSTROM @nephstrom]

#Diabetes and #COVID19? An Italian study found that about half of patients admitted to the hospital for COVID-19 during the start of the pandemic had new cases of hyperglycemia or high levels of blood sugar. They also had poorer outcomes. @NatMetabolism https://t.co/w5q5Viby3u

[NEPHSTROM @nephstrom]

Congratulations to @nephstrom PI @hjanders_hans

[Nature Reviews Disease Primers @DiseasePrimers]

Our NEW Primer on Acute #kidney injury by @kellumja @PRomagnani @GAshuntantang @croncoIRRIV Zarbock and @hjanders_hans is now live! Check it out! https://t.co/oZ8HjbXxJf

[Nature Reviews Disease Primers @DiseasePrimers]

Get Primed on #AcuteKidneyInjury with our NEW PrimeView, FREE to download this week https://t.co/4RAOOaB8ep

[Nature Reviews Disease Primers @DiseasePrimers]

The 2012 #AcuteKidneyInjury guidelines of the KDIGO group emphasizes AKI staging as a guide to management https://t.co/IhhooxSMFD

[Dr. Jan Nolta @jan_nolta]

We are thrilled that the Bridges Training grants for @sacstate and @humboldtstate are recommended for funding. These programs train outstanding, diverse scientists for the #celltherapy and #genetherapy workforce. We are fortunate to have their interns with us at @UCDavisStemCell.

[Paola Romagnani @PRomagnani]

AKI-related tubular epithelial cell loss requires adaptation of remaining nephrons and of the other tubular cells that respond by endoreplicating or proliferating https://t.co/R7m0pjJKLC
@DiseasePrimers @ERAEDTA @ASNKidney @ESPNSociety @ASPNeph @NDTsocial

[NEPHSTROM @nephstrom]

Patients with kidney disease—even without anaemia—may benefit from iron treatment #CKD https://t.co/kNRxijaM5n

[Hans-Joachim Anders @hjanders_hans]

#Kidney journal #impactfactors 2020 out. Congrats to @NatRevNeph @suz_allison @Kidney_Int @pi_ronco @JASN_News @JosiePBriggs @CJASN @NDTsocial @denisfouque1 @CKJsocial @CKJ_EiC @PepaSolerR and all others for great job in supporting research/new concepts/care for pts with KD

[Pintail Limited @PintailLimited]

@NEPHSTROM study “Burden of chronic kidney disease and rapid decline in renal function among adults attending a hospital-based diabetes center in Northern Europe” was the focus of a recent press release issued by NUI Galway https://t.co/lxgCEXJGHo

[NEPHSTROM @nephstrom]

Renquist and collaborators focus on fatty liver, measuring neurotransmitters from the liver in animal models of obesity to better understand how the liver communicates with the brain to influence metabolic changes seen in obesity and #diabetes https://t.co/NSCJZbwcAx @CellReports

[NEPHSTROM @nephstrom]

The #openaccess @nephstrom study titled “Burden of chronic kidney disease and rapid decline in renal function among adults attending a hospital-based diabetes center in Northern Europe” was the focus of a recent press release issued by NUI Galway. https://t.co/yiVSugrw6Y

[NEPHSTROM @nephstrom]

Latest @nephstrom publication! Burden of chronic kidney disease and rapid decline in renal function among adults attending a hospital-based diabetes center in Northern Europe https://t.co/ZtfKwXNTiJ